Vendor, Thousand Oaks, CA
Amgen USA Inc.
UEI XPGNQMXHP493, CAGE 5YNZ4
8 awards and $345,705,117 obligated between January 12, 2024 and August 19, 2026, 88% under full and open competition, against 126.3 offers on average where reported. 10 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $345,768,625 |
| Department of Veterans Affairs | -$63,508 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $345,768,625 |
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 | $0 |
| Pharmaceutical Preparation ManufacturingNAICS 325412 | -$63,508 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 7 |
| Not Competed | 1 |
| Definitive Contract | 2 |
| Delivery Order | 2 |
Hear when Amgen USA Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Amgen USA Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to Office of Assistant Secretary for Preparedness and Response, by dollars.
| Advanced Technology InternationalSummerville, SC | $2,764,576,471 |
| Albert B. Sabin Vaccine Institute, Inc. (The)Washington, DC | $356,898,734 |
| Start2 Group, Inc.Cambridge, MA | $227,139,021 |
| Siga Technologies, Inc.New York, NY | $177,835,284 |
| Shionogi Inc.Florham Park, NJ | $156,109,904 |
| Mapp Biopharmaceutical, Inc.San Diego, CA | $134,279,350 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Trastuzumab and Biosimilars (VA-25-00052526)
Department of Veterans Affairs, Nac Pharmaceuticals
Combined synopsis and solicitationNAICS 325412Anywhere in the US36E79725R0038Awarded to Amgen USA Inc.
Posted Jul 8, 20253 publications - Calcitonin Gene-Related Peptides (CGRP)
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 325412Anywhere in the US36E79724R0030Awarded to Amgen USA Inc. for $100,527,334
Posted Jan 13, 20255 publications - J&A Vendor Managed Inventory Neulasta Product
Office of Assistant Secretary for Preparedness and Response, Aspr Barda Div Contracts MGMT & Acq
JustificationThousand Oaks, CABARDA75A50124C00011Awarded to Amgen USA Inc. for $580,407
Posted Mar 12, 20242 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50122C00065Definitive Contract, February 5, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | No Cost Modification to Revise Section B.2.2, Clin Table Description Column for Clin0005.NAICS 541714, PSC AN13 | $344,956,700 |
| 75A50124C00011Definitive Contract, March 12, 2024, Not Competed, 1 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Vendor Managed Inventory (Vmi) Services for Usg Procured 165,906 Doses of Neulasta Product to Mitigate Injuries Caused by Exposure to ChemicNAICS 541714, PSC AN13 | $811,924 |
| 75A50118F33003Delivery Order, January 12, 2024, Full and Open Competition, 2 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | No Cost Modification to Correct the Period of Performance for Supplemental Funding for Clins 0001 and 0002.NAICS 325414, PSC AN13 | $0 |
| 36E79720D0006January 18, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Exercise the Fourth Option Year for Calcitonin Gene-Related PeptideNAICS 325412, PSC 6505 | $0 |
| 36E79725D0009January 13, 2025, Full and Open Competition, 1 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | 2 Line Items Calcitonin Gene-Related Peptides (Cgrp) Awarded for a Base Year Period of 2/26/2025 to 2/25/2026 Plus Four ONE-YEAR Option PeriNAICS 325412, PSC 6505 | $0 |
| 36E79725D0053September 2, 2025, Full and Open Competition, 3 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Trastuzumab with Amgen. Ordering Period Is Nov 15, 2025 Through Nov 14, 2026 with Four ONE-YEAR Options.NAICS 325412, PSC 6505 | $0 |
| 36F79721D0086February 1, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | 2024 Subk PlanNAICS 325412, PSC 6505 | $0 |
| 36C26024F0036Delivery Order, October 4, 2024, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Tavneos (Avacopan)NAICS 325412, PSC 6505 | -$63,508 |
- Places of performance
- CaliforniaTennessee
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development6505 Drugs and Biologicals
- Transactions
- 69 across 8 awards